ASCO 2019: Lymphoma Expert Discusses Advances in Targeted Therapies Joshua Brody, MD, Rebecca Seago-Coyle
Access to Effective Hodgkin Lymphoma Care at the Community Level Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
How Are Young Adults with Hodgkin Lymphoma Impacted by Treatment? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
What Should Hodgkin Lymphoma Patients Know About Survivorship? Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
An Expert Addresses Fertility Concerns for Hodgkin Lymphoma Patients Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
What Role Does Genetic Testing Play in Hodgkin Lymphoma Care? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Immunotherapy for Hodgkin Lymphoma Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
What Is the Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma Patients? Joshua Brody, MD, Esther Schorr, Andrew Schorr
